Slide Graphic or Logo

Biotech Innovation Series:
Stevenage Bioscience Catalyst

Join us in discussing the new challenges and opportunities emerging biotechs are facing in a post-pandemic era with a focus on managing risk when outsourcing and optimising drug development from bench to clinic at our inaugural Biotech Innovation Series event.

Date: May 4th 2022, 11am BST
Location: Stevenage Bioscience Catalyst, Gunnels Wood Road, Stevenage SG1 2FX
Duration: 90 mins (including lunch)

Slide Graphic or Logo

Biotech Innovation Series:
Stevenage Bioscience Catalyst

Join us in discussing the new challenges and opportunities emerging biotechs are facing in a post-pandemic era with a focus on managing risk when outsourcing and optimising drug development from bench to clinic at our inaugural Biotech Innovation Series event.

Date: May 4th 2022, 11am BST
Location: Stevenage Bioscience Catalyst, Gunnels Wood Road, Stevenage SG1 2FX
Duration: 90 mins (including lunch)

Slide Graphic or Logo

Biotech Innovation Series:
Stevenage Bioscience Catalyst

Join us in discussing the new challenges and opportunities emerging biotechs are facing in a post-pandemic era with a focus on managing risk when outsourcing and optimising drug development from bench to clinic at our inaugural Biotech Innovation Series event.

Date: May 4th 2022, 11am BST
Location: Stevenage Bioscience Catalyst, Gunnels Wood Road, Stevenage SG1 2FX
Duration: 90 mins (including lunch)

About

Despite the adversity of recent years, deal making and investor expectations in emerging biotech companies saw unprecedented growth in 2021 with average share prices of European listed biotechs up 39% on 2020. Last summer, the European Medicines Agency (EMA) published a report highlighting its support for emerging biotechs with an approval rate of 89% across all Marketing Authorisation applications submitted by SMEs in 2020, over double the rate in 2016.

This year however, has seen a correction in the biotech markets already. The focus is returning to the generation of quality data, building truly differentiated platform technologies and delivering value to patients.

Join us in discussing the new challenges and opportunities emerging biotechs are facing in a post-pandemic era with a focus on managing risk when outsourcing and optimising drug development from bench to clinic at our inaugural Biotech Innovation Series event.

Come and meet us at the Stevenage Bioscience Catalyst, a world leading hub for biotech drug development.

Speakers

Session 1: Simplifying Supply Management to Achieve Efficient Operations
Daniel Pavitt – eClinical Solution Specialist, Medidata

Daniel Pavitt – eClinical Solution Specialist, Medidata

Session 2: Better Together: The power of Clinical Trial + Real World Data
Ben McConnochie – Director, Strategic Development, Acorn AI

Ben McConnochie – Director, Strategic Development, Acorn AI